SlideShare a Scribd company logo
ACUTE LYMPHOBLASTIC LEUKEMIA PROF.S.TITO’S UNIT M5 DR.M.ARIVUMANI
[object Object]
Normal marrow
Entire marrow replaced by blast
Marrow showing blasts
Relative frequencies of lymphoid malignancies NHL(62.4%)
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chromosomal abnormalities in ALL ABNORMALITIES ADULTS(%) CHILDREN(%) Normal karyotype 16-34 9 hypodiploidy 4-9 1 hyperdiploidy 2-9 25 t (9;22) 11-30 4 t (4;11) 3-7 6 t (10;14) 4-6 4 t (8;14) 4 2 t ( 1;19) 3 5 9p abnormality 5-16 7-13 6q abnormality 2-6 4-6 12p abnormality 4-5 22
Factors predisposing ALL GENETIC ENVRONMENTAL Downs,turner, klinefelter Ionising radiation Fanconi,diamond blackfan Drugs NF Type1 alkylating agents Ataxia telengiectasia nitrosourea SCID epipodophyllotoxin PNH benzene exposure Li-fraumeni syndrome advanced maternal age Blooms syndrome paternal smoking
FAB CLASSIFICATION OF ALL CYTOLOGIC FEATURES L1 L2 L3 Cell size Small cells predominate,homogenous Large,heterogenous in size Large homogenous cytoplasm Scanty Variable,often moderately abundant Moderately abundant nucleoli Small One or more,often large One or more,prominent Nuclear shape Homogenous Variable, heterogenous Stippled, homogenous Nuclear shape Regular Irregular clefts regular Cyt.basophilia variable variable Intensely basophilic Cyt.vacuolation variable variable prominent
Classification of ALL(WHO) Immunologic subtype % of cases FAB subtype Cytogenetic  abnormalites Pre B ALL 75 L1,L2 t(9;22),t(4;11)t(1;19) Tcell  ALL 20 L1,L2 14q11 or 7q34 Mature Bcell ALL(burkitt leukemia) 5 L3 t(8;14)
Pre B ALL(L1) Small blasts wth thin rim of cytoplasm
T Cell ALL(L1)
T Cell ALL (L2) Irregular clefts of nucleus
Burkitt leukemia-Mature B Cell ALL(L3)-vacuolations
CNS Leu k emia (csf showing  blasts)
B Cell ALL (85%) type tdt CALLA Surface  Ig Early pro B ALL positive negative negative Pre Bcell ALL positive positive negative Mature B ALL negative positive positive
T Cell ALL(15%) ,[object Object],[object Object],[object Object],[object Object],[object Object]
T Cell ALL(CD3 Positive)
CLINICAL FEATURES ,[object Object],[object Object],[object Object],[object Object]
Symptoms  symptoms percentage fatigue 92 Bone or joint pain 79 fever 71 Weight loss 66 Abnormal masses 62 purpura 51 Other haemorrhage 27 infection 17
Physical findings Physical findings percentage splenomegaly 86 lymphadenopathy 76 hepatomegaly 74 Sternal tenderness 69 purpura 50 Fundic changes 14
Investigations ,[object Object],[object Object]
Confirmatory  Bone marrow aspiration/biopsy
Bone marrow biopsy(gross specimen)
Criteria for diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object]
Investigation (cont) ,[object Object],[object Object]
Investigation (cont) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Supportive care ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Preinduction ,[object Object],[object Object]
Treatment of ALL Induction 1 cycle chemotherapy Dose and schedule Induction Prednisolone or 1mg/kg  p.o days 1-28 days vincristine 1.5mg/m2  i.v weekly one dose  x 4 weeks doxorubicin 30mg/m2 i.v  weekly one dose x 4 weeks L-Asparginase 1,00,000 u/m2(total dose) in divided doses of 10,000  u daily for 10 days CNS Preventive therapy methotrexate 12mg IT days 1,8,15,22
Reassess ,[object Object],[object Object],[object Object],[object Object]
Induction 2 Induction2  drugs Dose and schedule Cyclophosphamide Cytosine arabinoside 650mg/m2 i.v days 1 and 15 75mg/m2  i.v x 4 days a weeks  for 4 week i.e day 1-4,8-11,15-18,22-25 methotrexate 12mg/m2 IT days 1,8,15,22 Cranial radiation 200 cGy x 9days
Reinduction Reinduction drug Dose  and schedule vincristine 1.5 mg/m2  i.v weekly one dose on day 1 and 8 doxorubicin 30mg/m2 i.v.  weekly one dose on day 1 and 8 prednisolone 1mg/kg p.o daily for 14 days
consolidation  consoldation drugs Dose and schedule cyclophosphamide 750/m2 .i.v days 1 and 15 Cytosine arabinoside 75mg/m2  doses days 1-4 and 15-18
Maintenance phase  duration- upto 2 years maintenance drug Dose and schedule 1 st   month methotrexate 12.5mg i.t on day 1 vincristine 1.4mg/m2 .v day 1 prednisolone 1mg/kg  p.o daily day 1-7 6 mercaptopurine 60mg/m2 p.o. daily for next  3 weeks  methotrexate 15mg/m2 p.o. once a  week for 3 weeks. 2 nd   month 6 MCP and T.Methotxerate for 4 weeks.
Follow up ,[object Object],[object Object]
Refractory ALL
Allogenic stem cell transpantation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Newer drugs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Late effects of treatment ,[object Object],[object Object],[object Object],[object Object],[object Object]
Relapse ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cns relapse
Prognostic factors in ALL Determinants Favourable unfavourable WBC Counts <10,000 >2,00,000 Age 2-10 years <1yr,>10yr Gender female male Ethnicity white blac Node,liver,splenomegaly absent massive Testicular enlargement absent present CNS involvement absent Csf blast and pleocytosis FAB Type L1 L2 Cytogenetics T(12;21)(TEL-AML1) Trsomies 4,10,17 t(9;22)(bcr-abl) t(4;11)(MLL-AF4) Ploidy hyperdipoidy hypodiploidy Time to remission <14days >28days
References. 1.Harrison’s principles of internal medicine 17 th  edition 2.Williams hematology 8 th  edition 3.Wintrobe’s clinical hematology  4.Nelson textboo K  of paediatrics 5.ash.hematologylibrary.com/image ban k.
THANK YOU

More Related Content

What's hot

Hodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins LymphomasHodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins Lymphomas
Dinoosh De Livera
 
Haematological Malignancies
Haematological MalignanciesHaematological Malignancies
Haematological Malignanciesmeducationdotnet
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemiaJasmine John
 
Acute leukemias
Acute leukemiasAcute leukemias
Acute leukemias
Vijay Shankar
 
Lymphoma
Lymphoma Lymphoma
Lymphoma
OM VERMA
 
Lymphoma
LymphomaLymphoma
Lymphoma
Mahesh Raj
 
Tumor Lysis Syndrome
Tumor Lysis SyndromeTumor Lysis Syndrome
Tumor Lysis Syndrome
CSN Vittal
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
DrHarpreet Bhatia
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
Joyshree Panda
 
Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML)Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML)
Dr Shumayla Aslam-Faiz
 
Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
anil kumar g
 
Lymphoma
LymphomaLymphoma
Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
Vijay Shankar
 
BURKITTS LYMPHOMA
 BURKITTS LYMPHOMA BURKITTS LYMPHOMA
BURKITTS LYMPHOMA
ALIYU USMAN MUHAMMAD
 
Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
Subhash Thakur
 
Approach to pancytopenia
Approach to pancytopeniaApproach to pancytopenia
Chronic myeloid Leukemia
Chronic myeloid LeukemiaChronic myeloid Leukemia
Chronic myeloid Leukemia
MLT LECTURES BY TANVEER TARA
 
AML vs ALL 5th Semester
AML vs ALL 5th SemesterAML vs ALL 5th Semester
AML vs ALL 5th Semester
MLT LECTURES BY TANVEER TARA
 
Tumors of infancy n childhood
Tumors of infancy n childhoodTumors of infancy n childhood
Tumors of infancy n childhood
9890888615
 

What's hot (20)

Hodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins LymphomasHodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins Lymphomas
 
Haematological Malignancies
Haematological MalignanciesHaematological Malignancies
Haematological Malignancies
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
 
Acute leukemias
Acute leukemiasAcute leukemias
Acute leukemias
 
Chronic Myeloid Leukaemia
Chronic Myeloid LeukaemiaChronic Myeloid Leukaemia
Chronic Myeloid Leukaemia
 
Lymphoma
Lymphoma Lymphoma
Lymphoma
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Tumor Lysis Syndrome
Tumor Lysis SyndromeTumor Lysis Syndrome
Tumor Lysis Syndrome
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
Chronic lymphocytic leukemia
Chronic lymphocytic leukemiaChronic lymphocytic leukemia
Chronic lymphocytic leukemia
 
Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML)Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML)
 
Acute leukemia
Acute leukemia Acute leukemia
Acute leukemia
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
 
BURKITTS LYMPHOMA
 BURKITTS LYMPHOMA BURKITTS LYMPHOMA
BURKITTS LYMPHOMA
 
Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia (CLL)
 
Approach to pancytopenia
Approach to pancytopeniaApproach to pancytopenia
Approach to pancytopenia
 
Chronic myeloid Leukemia
Chronic myeloid LeukemiaChronic myeloid Leukemia
Chronic myeloid Leukemia
 
AML vs ALL 5th Semester
AML vs ALL 5th SemesterAML vs ALL 5th Semester
AML vs ALL 5th Semester
 
Tumors of infancy n childhood
Tumors of infancy n childhoodTumors of infancy n childhood
Tumors of infancy n childhood
 

Viewers also liked

Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
MLT LECTURES BY TANVEER TARA
 
Acute lymphoid leukemia (case presentation)
Acute lymphoid leukemia (case presentation)Acute lymphoid leukemia (case presentation)
Acute lymphoid leukemia (case presentation)Dhritiman Chakrabarti
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid LeukemiaAli Swailmeen
 
Genetic Markers in AML
Genetic Markers in AMLGenetic Markers in AML
Genetic Markers in AML
Ferdie Fatiga
 
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
Ankit Raiyani
 
Acute leukaemia
Acute leukaemia Acute leukaemia
Acute leukaemia
NITISH SHAH
 
Leukaemia for bds
Leukaemia for bdsLeukaemia for bds
Leukaemia for bds
Sunil Rao
 
leukemias
leukemiasleukemias
leukemias
drsapnaharsha
 

Viewers also liked (9)

Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia
 
Acute lymphoid leukemia (case presentation)
Acute lymphoid leukemia (case presentation)Acute lymphoid leukemia (case presentation)
Acute lymphoid leukemia (case presentation)
 
Acute Myeloid Leukemia
Acute Myeloid LeukemiaAcute Myeloid Leukemia
Acute Myeloid Leukemia
 
Genetic Markers in AML
Genetic Markers in AMLGenetic Markers in AML
Genetic Markers in AML
 
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues : 2016 U...
 
Childhood Acute Lymphoblastic Leukemia
Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia
Childhood Acute Lymphoblastic Leukemia
 
Acute leukaemia
Acute leukaemia Acute leukaemia
Acute leukaemia
 
Leukaemia for bds
Leukaemia for bdsLeukaemia for bds
Leukaemia for bds
 
leukemias
leukemiasleukemias
leukemias
 

Similar to Acute Lymphoblastic Leukaemia

non hodgkin lymphoma
non hodgkin lymphomanon hodgkin lymphoma
non hodgkin lymphoma
Dr. Ankita Pandey
 
Membranous Nephropathy
Membranous NephropathyMembranous Nephropathy
Membranous Nephropathy
edwinchowyw
 
Radiotherapy in leukemias kiran
Radiotherapy  in leukemias kiranRadiotherapy  in leukemias kiran
Radiotherapy in leukemias kiran
Kiran Ramakrishna
 
leukemia (1).pptx
leukemia (1).pptxleukemia (1).pptx
leukemia (1).pptx
PriyaA811347
 
TREATMENT_OF_MYELOID_LEUKEMIA Final.pptx
TREATMENT_OF_MYELOID_LEUKEMIA Final.pptxTREATMENT_OF_MYELOID_LEUKEMIA Final.pptx
TREATMENT_OF_MYELOID_LEUKEMIA Final.pptx
Pavan Sagar
 
CASE SENERIO Dr Ayman RefaieMD
 CASE SENERIO  Dr Ayman RefaieMD CASE SENERIO  Dr Ayman RefaieMD
CASE SENERIO Dr Ayman RefaieMD
FAARRAG
 
Renal transplant 2
Renal transplant 2Renal transplant 2
Renal transplant 2
Sunny Benson
 
Seminar on acute lymphoblastic leukemia by Dr. Prachi Kalra
Seminar on acute lymphoblastic leukemia by Dr. Prachi KalraSeminar on acute lymphoblastic leukemia by Dr. Prachi Kalra
Seminar on acute lymphoblastic leukemia by Dr. Prachi Kalra
MAMC,Delhi
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRHMBONCO
 
Kidney cancers
Kidney cancersKidney cancers
Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...
Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...
Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...
Marwa Khalifa
 
Pegs m abs in rx ms
Pegs m abs in rx msPegs m abs in rx ms
Pegs m abs in rx ms
BartsMSBlog
 
leukemia in children with difference btw all and bll
leukemia in children with difference btw all and bllleukemia in children with difference btw all and bll
leukemia in children with difference btw all and bll
PriyankaGanani1
 
TREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTS
TREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTSTREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTS
TREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTSspa718
 
Hl &amp; Tls Presentation
Hl &amp; Tls PresentationHl &amp; Tls Presentation
Hl &amp; Tls Presentationflutterbye_xo
 
Leukemia in Children
Leukemia in ChildrenLeukemia in Children
Leukemia in Children
CSN Vittal
 
Childhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapiesChildhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapiesnephropdt
 
Leukaemia lecture 02 ALL transcript
Leukaemia lecture 02   ALL transcriptLeukaemia lecture 02   ALL transcript
Leukaemia lecture 02 ALL transcript
Rabiul Haque
 
ACUTE MYELOID LEUKEMIA
ACUTE MYELOID LEUKEMIAACUTE MYELOID LEUKEMIA
ACUTE MYELOID LEUKEMIA
flasco_org
 

Similar to Acute Lymphoblastic Leukaemia (20)

9th non hodgkin's
9th non hodgkin's9th non hodgkin's
9th non hodgkin's
 
non hodgkin lymphoma
non hodgkin lymphomanon hodgkin lymphoma
non hodgkin lymphoma
 
Membranous Nephropathy
Membranous NephropathyMembranous Nephropathy
Membranous Nephropathy
 
Radiotherapy in leukemias kiran
Radiotherapy  in leukemias kiranRadiotherapy  in leukemias kiran
Radiotherapy in leukemias kiran
 
leukemia (1).pptx
leukemia (1).pptxleukemia (1).pptx
leukemia (1).pptx
 
TREATMENT_OF_MYELOID_LEUKEMIA Final.pptx
TREATMENT_OF_MYELOID_LEUKEMIA Final.pptxTREATMENT_OF_MYELOID_LEUKEMIA Final.pptx
TREATMENT_OF_MYELOID_LEUKEMIA Final.pptx
 
CASE SENERIO Dr Ayman RefaieMD
 CASE SENERIO  Dr Ayman RefaieMD CASE SENERIO  Dr Ayman RefaieMD
CASE SENERIO Dr Ayman RefaieMD
 
Renal transplant 2
Renal transplant 2Renal transplant 2
Renal transplant 2
 
Seminar on acute lymphoblastic leukemia by Dr. Prachi Kalra
Seminar on acute lymphoblastic leukemia by Dr. Prachi KalraSeminar on acute lymphoblastic leukemia by Dr. Prachi Kalra
Seminar on acute lymphoblastic leukemia by Dr. Prachi Kalra
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And Management
 
Kidney cancers
Kidney cancersKidney cancers
Kidney cancers
 
Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...
Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...
Prognostic significance of microRNA 17–92 cluster expression in Egyptian chro...
 
Pegs m abs in rx ms
Pegs m abs in rx msPegs m abs in rx ms
Pegs m abs in rx ms
 
leukemia in children with difference btw all and bll
leukemia in children with difference btw all and bllleukemia in children with difference btw all and bll
leukemia in children with difference btw all and bll
 
TREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTS
TREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTSTREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTS
TREATMENT OF NON-HIDGKIN'S LYMPHOMA IN ELDERLY PATIENTS
 
Hl &amp; Tls Presentation
Hl &amp; Tls PresentationHl &amp; Tls Presentation
Hl &amp; Tls Presentation
 
Leukemia in Children
Leukemia in ChildrenLeukemia in Children
Leukemia in Children
 
Childhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapiesChildhood nephrotic syndrome—current and future therapies
Childhood nephrotic syndrome—current and future therapies
 
Leukaemia lecture 02 ALL transcript
Leukaemia lecture 02   ALL transcriptLeukaemia lecture 02   ALL transcript
Leukaemia lecture 02 ALL transcript
 
ACUTE MYELOID LEUKEMIA
ACUTE MYELOID LEUKEMIAACUTE MYELOID LEUKEMIA
ACUTE MYELOID LEUKEMIA
 

More from Stanley Medical College, Department of Medicine

More from Stanley Medical College, Department of Medicine (20)

Interpretation of Liver Function Tests
Interpretation of Liver Function TestsInterpretation of Liver Function Tests
Interpretation of Liver Function Tests
 
A Case of Sheehan's Syndrome
A Case of Sheehan's SyndromeA Case of Sheehan's Syndrome
A Case of Sheehan's Syndrome
 
Imaging: Cortical Vein Thrombosis
Imaging: Cortical Vein ThrombosisImaging: Cortical Vein Thrombosis
Imaging: Cortical Vein Thrombosis
 
ECG: Findings in CNS disorders
ECG: Findings in CNS disordersECG: Findings in CNS disorders
ECG: Findings in CNS disorders
 
A Case of Arrhythmogenic Right Ventricular Dysplasia - ARVD
A Case of Arrhythmogenic Right Ventricular Dysplasia - ARVDA Case of Arrhythmogenic Right Ventricular Dysplasia - ARVD
A Case of Arrhythmogenic Right Ventricular Dysplasia - ARVD
 
A Case of NASH with HYPOTHYROIDISM
A Case of NASH with HYPOTHYROIDISMA Case of NASH with HYPOTHYROIDISM
A Case of NASH with HYPOTHYROIDISM
 
IMAGING: NEUROCYSTICERCOSIS
IMAGING: NEUROCYSTICERCOSISIMAGING: NEUROCYSTICERCOSIS
IMAGING: NEUROCYSTICERCOSIS
 
ECG: Digitalis Effect / MAT / AF
ECG: Digitalis Effect / MAT / AFECG: Digitalis Effect / MAT / AF
ECG: Digitalis Effect / MAT / AF
 
Imaging: BOOP
Imaging: BOOPImaging: BOOP
Imaging: BOOP
 
ECG: Hypokalemia
ECG: HypokalemiaECG: Hypokalemia
ECG: Hypokalemia
 
A Case of Idiopathic Pulmonary Hypertension
A Case of Idiopathic Pulmonary HypertensionA Case of Idiopathic Pulmonary Hypertension
A Case of Idiopathic Pulmonary Hypertension
 
A Case of Schmidt Syndrome
A Case of Schmidt Syndrome A Case of Schmidt Syndrome
A Case of Schmidt Syndrome
 
A Case of Rodenticide Poisoning
A Case of Rodenticide PoisoningA Case of Rodenticide Poisoning
A Case of Rodenticide Poisoning
 
A Case of Emphysematous Pylonephritis
A Case of Emphysematous Pylonephritis A Case of Emphysematous Pylonephritis
A Case of Emphysematous Pylonephritis
 
Imaging: Multiple Pulmonary Cavitary Lesions
Imaging: Multiple Pulmonary Cavitary LesionsImaging: Multiple Pulmonary Cavitary Lesions
Imaging: Multiple Pulmonary Cavitary Lesions
 
ECG: Atrial Dissociation
ECG: Atrial DissociationECG: Atrial Dissociation
ECG: Atrial Dissociation
 
A Case of Hepato-Pulmonary Syndrome
A Case of Hepato-Pulmonary SyndromeA Case of Hepato-Pulmonary Syndrome
A Case of Hepato-Pulmonary Syndrome
 
A Case of Thalassemia
A Case of ThalassemiaA Case of Thalassemia
A Case of Thalassemia
 
A Case of Renal Amyloidosis
A Case of Renal AmyloidosisA Case of Renal Amyloidosis
A Case of Renal Amyloidosis
 
CXR: Silico-Tuberculosis
CXR: Silico-TuberculosisCXR: Silico-Tuberculosis
CXR: Silico-Tuberculosis
 

Recently uploaded

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 

Recently uploaded (20)

Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 

Acute Lymphoblastic Leukaemia

  • 1. ACUTE LYMPHOBLASTIC LEUKEMIA PROF.S.TITO’S UNIT M5 DR.M.ARIVUMANI
  • 2.
  • 6. Relative frequencies of lymphoid malignancies NHL(62.4%)
  • 7.
  • 8. Chromosomal abnormalities in ALL ABNORMALITIES ADULTS(%) CHILDREN(%) Normal karyotype 16-34 9 hypodiploidy 4-9 1 hyperdiploidy 2-9 25 t (9;22) 11-30 4 t (4;11) 3-7 6 t (10;14) 4-6 4 t (8;14) 4 2 t ( 1;19) 3 5 9p abnormality 5-16 7-13 6q abnormality 2-6 4-6 12p abnormality 4-5 22
  • 9. Factors predisposing ALL GENETIC ENVRONMENTAL Downs,turner, klinefelter Ionising radiation Fanconi,diamond blackfan Drugs NF Type1 alkylating agents Ataxia telengiectasia nitrosourea SCID epipodophyllotoxin PNH benzene exposure Li-fraumeni syndrome advanced maternal age Blooms syndrome paternal smoking
  • 10. FAB CLASSIFICATION OF ALL CYTOLOGIC FEATURES L1 L2 L3 Cell size Small cells predominate,homogenous Large,heterogenous in size Large homogenous cytoplasm Scanty Variable,often moderately abundant Moderately abundant nucleoli Small One or more,often large One or more,prominent Nuclear shape Homogenous Variable, heterogenous Stippled, homogenous Nuclear shape Regular Irregular clefts regular Cyt.basophilia variable variable Intensely basophilic Cyt.vacuolation variable variable prominent
  • 11. Classification of ALL(WHO) Immunologic subtype % of cases FAB subtype Cytogenetic abnormalites Pre B ALL 75 L1,L2 t(9;22),t(4;11)t(1;19) Tcell ALL 20 L1,L2 14q11 or 7q34 Mature Bcell ALL(burkitt leukemia) 5 L3 t(8;14)
  • 12. Pre B ALL(L1) Small blasts wth thin rim of cytoplasm
  • 14. T Cell ALL (L2) Irregular clefts of nucleus
  • 15. Burkitt leukemia-Mature B Cell ALL(L3)-vacuolations
  • 16. CNS Leu k emia (csf showing blasts)
  • 17. B Cell ALL (85%) type tdt CALLA Surface Ig Early pro B ALL positive negative negative Pre Bcell ALL positive positive negative Mature B ALL negative positive positive
  • 18.
  • 19. T Cell ALL(CD3 Positive)
  • 20.
  • 21. Symptoms symptoms percentage fatigue 92 Bone or joint pain 79 fever 71 Weight loss 66 Abnormal masses 62 purpura 51 Other haemorrhage 27 infection 17
  • 22. Physical findings Physical findings percentage splenomegaly 86 lymphadenopathy 76 hepatomegaly 74 Sternal tenderness 69 purpura 50 Fundic changes 14
  • 23.
  • 24. Confirmatory Bone marrow aspiration/biopsy
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32. Treatment of ALL Induction 1 cycle chemotherapy Dose and schedule Induction Prednisolone or 1mg/kg p.o days 1-28 days vincristine 1.5mg/m2 i.v weekly one dose x 4 weeks doxorubicin 30mg/m2 i.v weekly one dose x 4 weeks L-Asparginase 1,00,000 u/m2(total dose) in divided doses of 10,000 u daily for 10 days CNS Preventive therapy methotrexate 12mg IT days 1,8,15,22
  • 33.
  • 34. Induction 2 Induction2 drugs Dose and schedule Cyclophosphamide Cytosine arabinoside 650mg/m2 i.v days 1 and 15 75mg/m2 i.v x 4 days a weeks for 4 week i.e day 1-4,8-11,15-18,22-25 methotrexate 12mg/m2 IT days 1,8,15,22 Cranial radiation 200 cGy x 9days
  • 35. Reinduction Reinduction drug Dose and schedule vincristine 1.5 mg/m2 i.v weekly one dose on day 1 and 8 doxorubicin 30mg/m2 i.v. weekly one dose on day 1 and 8 prednisolone 1mg/kg p.o daily for 14 days
  • 36. consolidation consoldation drugs Dose and schedule cyclophosphamide 750/m2 .i.v days 1 and 15 Cytosine arabinoside 75mg/m2 doses days 1-4 and 15-18
  • 37. Maintenance phase duration- upto 2 years maintenance drug Dose and schedule 1 st month methotrexate 12.5mg i.t on day 1 vincristine 1.4mg/m2 .v day 1 prednisolone 1mg/kg p.o daily day 1-7 6 mercaptopurine 60mg/m2 p.o. daily for next 3 weeks methotrexate 15mg/m2 p.o. once a week for 3 weeks. 2 nd month 6 MCP and T.Methotxerate for 4 weeks.
  • 38.
  • 40.
  • 41.
  • 42.
  • 43.
  • 45. Prognostic factors in ALL Determinants Favourable unfavourable WBC Counts <10,000 >2,00,000 Age 2-10 years <1yr,>10yr Gender female male Ethnicity white blac Node,liver,splenomegaly absent massive Testicular enlargement absent present CNS involvement absent Csf blast and pleocytosis FAB Type L1 L2 Cytogenetics T(12;21)(TEL-AML1) Trsomies 4,10,17 t(9;22)(bcr-abl) t(4;11)(MLL-AF4) Ploidy hyperdipoidy hypodiploidy Time to remission <14days >28days
  • 46. References. 1.Harrison’s principles of internal medicine 17 th edition 2.Williams hematology 8 th edition 3.Wintrobe’s clinical hematology 4.Nelson textboo K of paediatrics 5.ash.hematologylibrary.com/image ban k.